NCT00470184 - Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2012

Conditions

Esophageal Cancer

Interventions

DRUG

capecitabine

Oral

DRUG

oxaliplatin

GENETIC

gene expression analysis

Correlative Study

GENETIC

microarray analysis

Correlative Study

GENETIC

reverse transcriptase-polymerase chain reaction

Correlative Study

PROCEDURE

adjuvant therapy

Metastatic growth control

PROCEDURE

biopsy

Examination of tissue type

PROCEDURE

conventional surgery

Tissue removal

PROCEDURE

neoadjuvant therapy

Tumor shrinkage

PROCEDURE

quality-of-life assessment

Correlative Study

RADIATION

radiation therapy

Undergoing radiation therapy

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors

collaborator

National Comprehensive Cancer Network

NETWORK

lead

Roswell Park Cancer Institute

OTHER